Effectiveness of Patient-Directed Education to Sustain Deprescribing: A Pragmatic Trial.

Background: More than one in three older adults use potentially inappropriate medications (PIMs), and those with chronic conditions are more likely to be on multiple PIMs. Deprescribing, defined as stopping or dose-reducing a medication, can avoid harms from PIMs. Despite its benefits, deprescribing...

Descripción completa

Detalles Bibliográficos
Publicado en:Drugs & Aging Vol. 42; no. 11; pp. 1073 - 1084
Autores principales: Jones, Katie Fitzgerald, Stolzmann, Kelly, Wormwood, Jolie, Pendergast, Jacquelyn, Miller, Christopher J., Still, Michael, Bokhour, Barbara G., Hanlon, Joseph, Simon, Steven R., Rosen, Amy K., Linsky, Amy M.
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Springer Nature Nov2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188949811&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 188949811
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1170229X
        C5B
      jtl: Drugs & Aging
      issn: 1170229X
      maglogo: N
    pubinfo:
      dt: Nov2025
      vid: 42
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        188949811
        188705502
        188949811
        188949811
        10.1007/s40266-025-01251-z
        188949811
      ppf: 1073
      ppct: 11
      formats:
      tig:
        atl: Effectiveness of Patient-Directed Education to Sustain Deprescribing: A Pragmatic Trial.
      aug:
        au:
          Jones, Katie Fitzgerald
          Stolzmann, Kelly
          Wormwood, Jolie
          Pendergast, Jacquelyn
          Miller, Christopher J.
          Still, Michael
          Bokhour, Barbara G.
          Hanlon, Joseph
          Simon, Steven R.
          Rosen, Amy K.
          Linsky, Amy M.
        affil: https://ror.org/04v00sg98 New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, 150 South Huntington Ave, 02130, Jamaica Plain, MA, USA
      sug:
        subj:
          Patient Education
          Outcomes of Education
          Patient Safety
          Patient Participation
          Implementation Science
          Deprescribing
          Proton Pump Inhibitors Administration and Dosage
          Gabapentin Administration and Dosage
          Hypoglycemic Agents Administration and Dosage
          Human
          Randomized Controlled Trials
          Random Assignment
          Inappropriate Prescribing Prevention and Control
          Clinical Assessment Tools
          Hypoglycemia Risk Factors
          Risk Assessment
          Prospective Studies
          Multiple Logistic Regression
          Odds Ratio
          Descriptive Statistics
          Confidence Intervals
          Primary Health Care
          Hospitals, Veterans
          California
          New York
          Massachusetts
          Multicenter Studies
          Physicians, Family
          Primary Care Nurse Practitioners
          Physician Assistants
          Data Analysis Software
          T-Tests
          Chi Square Test
          Funding Source
      ab: Background: More than one in three older adults use potentially inappropriate medications (PIMs), and those with chronic conditions are more likely to be on multiple PIMs. Deprescribing, defined as stopping or dose-reducing a medication, can avoid harms from PIMs. Despite its benefits, deprescribing is rarely adopted into clinical practice. Objectives: We examined the effectiveness, sustainability, and safety of a patient-engagement strategy in a pragmatic trial at three facilities. Methods: Subjects were mailed brochures for one of three PIMs (proton pump inhibitors, high-dose gabapentin, and diabetes agents with hypoglycemia risk) if they had chronic active prescriptions before a primary care provider (PCP) visit. Control subjects received usual care. Results: There were 2448 patients in the control group (n = 2448) and 2480 patients in the implementation strategy cohort (n = 2480). In a mixed effect multivariable logistic regression model with PCP and site treated as random factors and controlling for patient and PCP characteristics, implementation strategy patients were significantly more likely to have deprescribing at 12-months compared with controls (odds ratio [OR] = 1.19; 95% confidence interval [CI] = 1.04, 1.35; p = 0.012). In a multinomial logistic regression model controlling for patient characteristics, implementation strategy patients were significantly more likely to exhibit sustained deprescribing (deprescribing at 6 and 12 months, OR = 1.32 [95% CI = 1.13, 1.55]) but not short-term (6 months only, OR = 0.96 [95% CI = 0.79, 1.16]) or delayed (12 months only, OR = 0.99 [95% CI = 0.84, 1.17]) deprescribing. There were five potential severe adverse drug withdrawals (0.2% incidence rate) possibly related to deprescribing. Conclusions: Despite low intensity, patient-directed education materials are an effective and safe implementation strategy to promote and sustain deprescribing. Trial Registration: ClinicalTrials.gov, NCT0429490, NCT04294901.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N